Turnover
≈ €230,000 estimated
The micro format states no turnover.
VSMA
Lifetime
1 annual account with figurespeak €123,902 (2025)
€123,902
peak €54,889 (2025)
€54,889
peak €55,889 (2025)
€55,889
€104,058
Board1 name since 2025
1 directorVanderstappen Maxim
Documentsfilings and deeds
29-08-202629 days late
2025micro format
Incorporation 21-021 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€1,000 100 shares
2025 accounts filed 29 days after the deadline
Checked score
93
Excellent
Financially stronger than 47% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
03-2026: 0.3%
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.4%▲ +0.1 percentage points vs 07-2026highest value
09-2026: < 0.1%▼ -0.4 percentage points vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 1.38, cash €29,613
Size: total assets €159,947
Figures for financial year 2025 (filed on 29-08-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 29% of them on solvency, 31% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as VSMA has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of VSMA itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for VSMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.38, below the usual 1.5. Short-term debt is 38.8% and cash 18.5% of total assets. 65.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
raises risk · 2025 accounts filed 29 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
29 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1020195619
Incorporation
Founding capital of €1,000, 100 shares · Founder: Vanderstappen Maxim (oprichter comparant) · Appointment: Vanderstappen Maxim (director) · published on 21-02-2025 · Gazette deed
First establishment
Grimbertlaan 21, Schoten
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| VSMA Schoten | €159,947 | €123,902 | 34.9% | - |
| Dr. Maarten Rombauts Lier | €146,643 | €122,036 | 73.4% | - |
| Marie Van Isacker Sint-Niklaas | €159,004 | €126,906 | 62.1% | - |
| AnesTHeezy Wezembeek-Oppem | €156,828 | €137,976 | 63.3% | - |
| Docteur Adrien LOHEAC Ciney | €150,741 | €117,276 | 83.0% | - |
| SCornet Dalhem | €159,510 | €134,711 | 85.9% | - |
| MLR Anesthesia Brussels | €141,164 | €136,858 | 76.4% | - |
These companies have the same main activity as VSMA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €141,000 and €160,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 19-02-2025Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.373.117.2722900 Schoten, since 19-02-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 26-03-2025
Insights on VSMA
VSMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €55,889 and a net result of €54,889.
Its solvency ranks better than 29% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about VSMA
- What is the company number of VSMA?
- The company number of VSMA is 1020.195.619. The VAT number is the same number with BE in front: BE 1020.195.619.
- Where is VSMA based?
- The registered office is at Grimbertlaan 21, 2900 Schoten.Company details
- What does VSMA do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of VSMA?
- VSMA is a private limited company (BV).
- When was VSMA founded?
- VSMA was founded on 19-02-2025.
- Is VSMA still active?
- Yes, VSMA is an active enterprise in the KBO register.
- How many employees does VSMA have?
- VSMA had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does VSMA fall under?
- In its 2025 annual accounts, VSMA states joint committee 330 (Health institutions and services).
- What is the turnover of VSMA?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €123,902 and 41 comparable companies (NACE 86220). It probably lies between €200,000 and €310,000.
- Is VSMA profitable?
- In financial year 2025, VSMA made a profit of €54,889.
- Where can I find the annual accounts of VSMA?
- VSMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See whether the workforce is growing and whether people stay.Employer check
See how customers, suppliers and banks see your own company and what to improve first.